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Chemical modification of cell proliferation and fluid secretion in renal
cysts. We used an in vitro model, MDCK cyst, to determine the extent
to which pharmacologic compounds known to inhibit plasma membrane
solute transport mechanisms could alter the enlargement of renal
epithelial cysts. Solitary MDCK cells cultured within collagen gel
undergo clonal growth to form true epithelial cysts in which a single
layer of polarized cells (apex toward lumen) encloses a fluid-filled
cavity. Repeated observations by light microscopy were used to quan-
titate the rate of cyst growth in diameter, and demonstrated that cyst
enlargement involved an increase in cell number (proliferation) and a
net increase in intracystic volume (fluid secretion). Intracyst pressure
was greater than the interstitium (6.7 mm H20 3.1 SD), indicating that
fluid entry was secondary to net solute accumulation. Amiloride and
seven amiloride analogs that inhibited to different degrees conductive
Na transport, Na-dependent H transport and Natdependent Ca
transport reversibly decreased the rate of cyst enlargement. The
effectiveness of these agents to retard cyst enlargement correlated with
their relative potencies to inhibit Na-dependent Ca transport.
Morphologic examination indicated that amiloride and amiloride ana-
logs decreased cell proliferation and fluid secretion to the same degree.
Ouabain and vanadate (Na+K,ATPase inhibitors), and L-645,695
(Na-dependent Cl/HC03 inhibitor) potently slowed cyst expansion.
In contrast to amiloride and amiloride analogs, these agents caused an
unusual degree of cellular stratification within the cyst walls, a finding
consistent with the notion that fluid secretion was inhibited to a greater
extent then cellular proliferation. We conclude that chemical inhibitors
of primary and secondary active solute transport can diminish or halt
the enlargement of epithelial cysts in vitro by decreasing the rate of
cellular proliferation and/or net fluid secretion.
Epithelial cysts are usually composed of a single confluent
layer of cells enclosing a spherical cavity containing fluid or
semisolid material. Cysts may be found in the normal stages of
organ development and function, as for example in the ovary,
or in the initial stages of embryogenesis (blastocysts), or they
may represent pathological structures that in large numbers
ultimately compromise the function of the organs in which they
arise [1, 2].
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Renal cysts arise from the epithelium of tubules and Bow-
man's capsule [3]. In the major hereditary type, autosomal
dominant polycystic kidney disease, the cysts appear to de-
velop in utero in a relatively small fraction of the nephrons and
collecting ducts, and progressively enlarge to compromise renal
function in the fifth or sixth decade of life [1—3]. By contrast, the
autosomal recessive form of polycystic kidney disease develops
in utero in most of the collecting ducts resulting in death shortly
after birth in most cases [4, 5]. In the hereditary types of renal
cystic disease the cause is directly linked to mutated DNA,
whereas in the non-hereditary cystic disorders the causes are
unknown.
Recent studies of the dominantly-inherited cystic disease
indicate that epithelial proliferation and cavitary fluid accumu-
lation are critically important components of progressive cyst
enlargement. It is not known, however, whether cell prolifera-
tion or net fluid secretion are the primary events that stimulate
cyst expansion [6]. The linkage between cell proliferation and
net fluid secretion can now be addressed with the help of an in
vitro model of renal cyst enlargement. McAteer and coworkers
[7, 8] recently described an in vitro model of renal cyst
formation that incorporates the growth of MDCK cells within
medium-hydrated collagen gel. Individual MDCK cells sus-
pended in collagen gel proliferate and form epithelial cysts in
which the apical cell surfaces face the lumen. Each cyst
enlarges progressively for many days. The rate of cyst enlarge-
ment is influenced by the density of cysts in the gel, the
composition of the culture medium and the rigidity of the
collagen substrate [9, 10]. The transparent collagen gel permits
repeated light microscopic examination of individual cysts so
that the rate of cyst enlargement and cyst wall morphological
changes can be quantified.
MDCK cells are believed to be derived from distal tubule
epithelium [7, 8, II]. In monolayer cultures the cells express
many types of electrolyte transport, observed in differentiated
renal epithelia, including Na + K, ATPase [12], Na/H
exchange [13], Na/Ca exchange [141, Cl channels [15], K
channels [16], Na, K/2Cl cotransport [17], and Cl/HC03
exchange [18]. Transepithelial solute transport tied to one or
more of these processes may have a central role in modulating
the progressive fluid accumulation and cavitary enlargement of
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renal cysts derived from these cells. This unique model afforded
an opportunity to determine if the highly coordinated process of
cyst formation and enlargement could be altered by drugs that
affect solute transport processes. Therefore, in this study we
have surveyed the effect on the rate of MDCK cyst enlargement
in vitro of drugs known to interfere with a variety of transmem-
brane electrolyte transport processes. Morphological examina-
tion at the light and electron microscope level was also used to
determine the extent to which the drugs independently altered
cellular proliferation and net fluid secretion.
Methods
MDCK cells [19], obtained at passage 53 from American
Type Culture Collection, (Rockville, Maryland, USA), were
maintained as monolayer cultures in medium DME/F12 supple-
mented with 5 or 10% fetal bovine serum (FBS, Hyclone
Laboratories, Logan, Utah, USA) and contained 15 mr',i
HEPES, 1.2 mg/mI NaHCO3, 100 lU/mi penicillin and 100 pgJ
ml streptomycin. A single cell suspension was obtained by
incubating the monolayer culture in 0.05% trypsin solution [8]
followed by trituration with a 5 ml glass pipet. We used a
modification of the method of McAteer, Evan and Gardner [8]
to prepare MDCK cysts, by placing the appropriate number of
cells (determined by hemacytometer count) in ice-cold Vitrogen
(Collagen Corporation, Palo Alto, California, USA) that had
been neutralized with NaOH and to which culture medium
MEM, HEPES and NaHCO3 had been added. Gelation oc-
curred at 37° in 35 mm dishes, after which DME/F12 containing
5% FBS was added to each dish. In an effort to obtain a
homogeneous cell population for study we established sublines
derived from single MDCK cysts. We selected single spherical
cysts that were released from the gel following incubation in
collagenase (0.1%, Type 1, Cooper Biomedical, Malvern, Penn-
sylvania, USA). Single cysts were transferred into the wells of
a 24 well plate containing growth medium, and were propagated
and subcuitured to standard T-75 flasks. All of the studies we
describe were preformed on cells derived from a single cyst that
was harvested and propagated by this method. The subculture
of this cyst was enlarged to several million cells, portions of
which were stored frozen. Working stock cultures were pas-
saged each week. We monitored monolayer and cyst area
doubling times, and cyst plating efficiency to determine when
new working cultures should be produced from the frozen
stock.
To insure that the majority of cells would be randomly
distributed within the gel, rather than near or on the top or
bottom surfaces, we modified the McAteer et al method [8].
Cells were added to the ice-cold Vitrogen, then heated in a 37°
water bath for a predetermined time which was approximately
one minute before expected gelation. Cells suspended in Vitro-
gen were pipetted into the wells (0.4 mI/well) of a 24 well plate
prewarmed to 37°C. After gelation at 37°C, 1.5 ml of DME/Fl2
supplemented with 5% FBS was added to each well. Logarith-
mic increases in cyst surface area were achieved at seeding
densities of 300 to 3000 cells/well (vida infra). Medium overly-
ing the gel was changed three times per week. Culture plates
were maintained in a 5% CO2 atmosphere at 37°C (Queue CO,
Incubator, Parkersburg, West Virginia, USA).
Cyst growth rate was quantified by transferring the 24 well
plate to the stage of an inverted microscope (Unitron or Nikon)
700
500
400
300
200
100
U)
U)
E
(U
0
6 8
50
20 '°E010
x
5.0 (U
U)
(U
U,
2.0
1.0
0 2 4
Time, days
Fig. 1. Progressive enlargement of a solitary MDCK cyst in medium-
hydrated collagen gel. MDCK cells were seeded seven days before day
0 during which time the examined object enlarged from a single cell to
a cyst with an outside diameter of 55 itm. The outer diameter (mean of
3 diameter measurements) was used to calculate surface area (SA = ir
D2). Maximum cyst diameter in this example was 390 sm at 8 days. The
logarithmic rate of surface area increase in this example is typical of
cysts in the control condition in which medium contained FBS or
defined growth factors.
and individual cysts were located by focusing a low power (Sx)
bright-field objective into the midplane of the collagen gel. In
practice 0.4 ml of gel filled the 1.55 cm diameter well to a depth
of 2.5 mm. Cysts were allowed to grow to a diameter of 50 to
100 sm before actual measurements were begun. This prelimi-
nary period usually lasted 7 to 13 days after seeding the cells
into Vitrogen. A spherical single cyst in the midplane of the gel
could easily be brought into focus so that the outer diameter
could be measured at a final magnification of 50 to 200x with a
calibrated reticle mounted in the microscope ocular. Three
diameters intersecting at 60° angles were recorded at the
equator for each cyst and averaged. Only spherical cysts were
used. Surface area of the spherical cysts was calculated from
SA = ii D2. Individual cysts in the midplane of the gel were
identified in reference to marks on the bottom of each well. In
this way individual cysts could be measured repeatedly at
predetermined intervals (Fig. 1). At least three cysts were
measured in this way for each condition in an individual
experiment by a naive observer.
When fewer than 1000 cells were seeded per well too few
cysts developed in the midplane of the gel for convenient
analysis. With greater than 3000 cells per well, crowding
Fig. 2. Dependence of MDCK cyst growth on
media components. In these experiments
cysts were grown in defined medium (DME/
F12) containing FBS. On day 0, FBS was
removed and replaced with control (C)
medium containing ITS (insulin, transferrin,
selenium), HC (hydrocortisone), T3 (tn-
iodothyronine), and POEI (prostaglandin E1)
[28]. In some experiments selective deletions
of these components were made. The cysts
were fed with freshly prepared media 3 times
weekly. The log growth rate SE was
determined in 3 separate studies. *significant
difference (P < 0.05) from control (C).
diminished the rate of cyst enlargement within a few days and
there was excessive monolayer growth on the top and bottom
surfaces of the gel. At initial seeding densities between 300 and
3000 cells per well we observed a logarithmic increase in
surface area for at least 10 days. Cyst "efficiency", the per-
centage of cysts that developed from the original number of
implanted cells, was approximately 7%. The range of surface
area doubling times for cysts seeded at an initial cell density of
300 to 3000 was 38 to 78 hours.
The mean apical surface area of individual cells lining the
cysts was determined by bringing into sharp focus the apical
surfaces of cyst walls closest to the microscope objective.
These images were relayed by a Panasonic video camera onto
video tape, and replayed onto a monitor from which the outer
perimeter of 10 to 25 cells could be traced on mylar film. Groups
of cells in relatively flat surfaces were selected. Total surface
area of the enclosed cells was determined on an electronic
digitizing board, and mean area per cell was calculated by
dividing total surface area by the number of cells. To reduce the
effect of anisotropy, measurements were limited to a total of 25
or fewer contiguous cells. To determine the total number of
cells in a given cyst, the surface area (ITD2) was divided by the
mean apical cell area for that cyst. For electron microscopy, I
mm square sections of collagen gel were fixed in 2% glutaral-
dehyde and 1% paraformaldehyde, post-fixed in 1% osmium
tetroxide, dehydrated in an alcohol series and embedded in LR
white embedding medium. Thick sections (I m) were stained
with Lee's stain for light microscopy. Thin sections were
stained with uranyl acetate and lead citrate and examined in a
JEOL electron microscope (Tokyo, Japan).
Cyst growth rates in control and experimental conditions
were quantified by determining the rate of change in cyst
diameter and surface area in at least three cysts for each
condition in an individual study. The measurements of diameter
and derived surface area were begun 7 to 13 days after seeding
the cells and were usually repeated at intervals of I, 3, 7, and 10
days. To determine the effects of experimental treatments on
the rate of epithelial growth we determined the slopes of the
semi-logarithmic relation between time and the logarithm of
surface area for the intervals 1 to 3, 3 to 7, and 7 to 10 days for
each cyst. In control cysts, growth was always logarithmic until
the seventh day. Thus, to evaluate the effect of experimental
treatments on cyst growth we measured the rate of change in
cyst surface area (SA) between days I to 3 and 3 to 7. To
normalize the data the growth rates were determined from the
formula:
log growth rate = (log SAb — log SAa) (b — a),
where a is the initial measurement day and b is the next
measurement day. Drug effects were determined by plotting
[log growth rate (experimental)]/[log growth rate (control)] x
100 in relation to drug concentration. The concentration of drug
required to reduce cyst growth rate by 50% (IC50) was deter-
mined by interpolation.
To determine transepithelial hydrostatic pressure, individual
cysts were dissected from the collagen gel without collagenase
treatment by methods described previously for isolating single
kidney tubule fragments from slices of renal cortex and medulla
[20, 21]. Each cyst was dissected with a thin rim of collagen
matrix (<50 4itm) attached. A single cyst was held by gentle
suction applied to the collagen rim around the cyst using a
fluid-filled micropipet. Transcystic pressure was estimated by
directly puncturing the cavity with a second micropipet with a
15 to 20 pm tip that had been sharpened with a grinding stone.
Zero pressure was established before puncturing the cyst by
adjusting a column of fluid connected to the micropipet until
fluid neither ran into or out of the pipet tip. This was adduced by
observing the movement into and out of the pipet tip of small
particles of debris suspended in the medium. The cyst wall was
punctured and fluid from the cyst cavity entered the pipet. The
height of the fluid column was adjusted to expel all of the debris
back into the cyst cavity. The change in the height of the fluid
column required to eject the debris was taken to represent the
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Fig. 3. Effect of medium osmolalUy on growth rate of MDCK cells in
cyst configuration in medium-hydrated collagen gel. All cysts were
established 12 to 15 days before the measurements were started.
Control cysts (S) were observed for an additional 18 days in the
absence of changes in medium osmolality. Extracellular osmolality of
experimental media was increased by 300 mOsm in two ways, NaCI
concentration was increased 10 msi per day (U), or by 50 m on days
5, 10. and 15 (A). Significant differences between control and experi-
mental conditions were not observed.
net hydrostatic pressure difference across the wall of the
punctured cyst.
Statistical methods
Values are presented as mean standard deviation or
standard error since means and medians of grouped data were
comparable indicating normally distributed populations. Differ-
ences among more than two groups of data were evaluated by
one-way ANOVA and Tukey's test.
Media and reagents
For the experiments the standard growth medium was a 1:1
mixture of Dulbecco's modified Eagle's medium and Ham's F12
(KC Biological [Hazieton], Lenexa, Kansas, USA) containing
10mM HEPES (KC Biological [Hazelton]), 35 ms'i NaHCO 100
lU/mi penicillin 0 (Pfizer Pharmaceutical, New York, New
York, USA), and 5% FBS. For defined medium, ITS (insulin, 5
g/ml; transferrin, 5 g/ml; selenium, S nglml; Collaborative
Research, Lexington, Massachusetts, USA), hydrocortisone (5
x l0_8 M, Sigma Chemical Co., St. Louis, Missouri), T (33
5-triiodo-L-thyronine, 5 x 10— 12 M, Sigma) and POE1 (25 nglml,
Fig. 4. Analysis ofce/i proliferation rate in MDCK cysts. A. Cyst wall
focused to accentuate the outlines of individual cells. In this example
the cyst diameter was 417 m and the mean surface area of the cells was
153 tm7. Magnification l000x. B. The number of cells in cysts
increased in proportion to the increase in plane surface area of spherical
cysts. In this study 85 individual cysts of various sizes were dissected
from collagen gels and the walls viewed with a microscope, video
camera and monitor at high magnification as in A above. A range of cyst
sizes was chosen. The line represents the equation, cysts/cell = 163 +
59.3 x surface area (l04 m2). r2 = 0.86.
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Sigma) were added to the standard growth medium in lieu of
FBS. The trypsinization solution contained 8 g/liter NaCL, 0.4
g/liter KCI, I g/liter dextrose, 0.58 glliter NaHCO3, 0.2 g/liter
EDTA (disodium) and 0.5 g/liter trypsin (Difco 1:250).
Amiloride, 5-IN ,N-dimethyl]amiloride (DMA), 5-[N ,N-hexa-
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methylene]amiloride (HMA), 5-[N-methyl-N-isobutyl]amiloride
(MIBA), 5-[N-ethyt-N-isopropyl]amiloride (EIPA), 3' ,4'-dichloro-
benzamil (DCB), and 5-[N-(4-chlorobenzyl)I-2',4'-dimethytbenz-
amil (CBDMB) were prepared by the method of Cragoe et at [22].
MK-875 was prepared by the method of Shepard et at [23]. [(2-
Butyl-2-cyclopentyl-6,7-decloro-2,3-dihydroindanyl)oxy]acetic
acid (L-645,695) was prepared by the procedure of Woltersdorf
et at [24]. Ethacrynic acid was synthesized by the procedure of
Schultz et at [25]. Bumetanide was prepared by the procedure
of P.W. Feit [26]. R( +)[(5,6-Dichtoro-2,3 ,9,9a-tetrahydro-3-
oxo-9a-propyt-1-H-fluoren-7-ye)oxy]acetic acid (L-644,71 I)
was made by the method of Cragoe et at [27]. Acetazotamide
was purchased from the Aldrich Company, Milwaukee, Wis-
consin, USA.
Drugs were dissotved immediately prior to changing the
medium. Some amiloride analogs were sparingty soluble in
water and were dissotved in dimethyl sutfoxide (DMSO) before
addition to medium. An equivalent amount of DMSO was
added to the control welts. DMSO at the maximat concentra-
tions used in these studies (0.5%) had no effect on the rate of
cyst enlargement.
Results
The growth behavior on a conventional plastic substrate of
monolayers of MDCK cells in defined and serum enriched
media has been well characterized [28]. We were concerned
about the extent to which cells in the cysts reflected the growth
characteristics of the parent cell strain in monolayer culture.
Thus, we determined the influence of a variety of media
supplements on growth behavior of MDCK cyst cells within
collagen gets. As for MDCK cells grown in monolayers, the rate
of cell proliferation, reflected by cyst enlargement, was depen-
dent on several of the defined growth factors added to the DME/
F12 medium. Cyst growth was dependent on PGE1, and to a
lesser extent on the combination of insulin, transferrin, and
selenium in agreement with previous observations of MDCK
monolayers [28] (Fig. 2). Ten percent FBS promoted cyst
growth at a rate equal to that observed in defined medium; 5%
FBS yielded a cyst growth rate 28% less than the 10% FBS
medium (data not shown).
MDCK cells in monolayer culture withstand marked in-
creases in medium osmolality [29]. As an additional test of
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Fig. S. The effect of amiloride on the
enlargement of MDCK cysts in medium-200 hydrated collagen gel. This figure shows the
details of a single experiment. Amiloride was
added on day 0 to established cysts. Each line
100 represents an individual cyst. The medium
was changed 3 times per week. The
concentrations of amiloride are indicated in
LM. The dashed line indicates that the cyst's
walls became indistinct, and diameter could
not be measured. In this case growth rate was
assumed to be zero.
Fig. 6. Effect of duration of amiloride
exposure on growth of MDCK cysts. Three
separate experiments were analyzed as shown
in Figure 5, except that each point is the
mean of at least 3 cysts. One group shows the
relative rate of cyst growth over the interval I
to 3 days; the other shows relative cyst
growth over 3 to 7 days exposure to
1000 amiloride. The effectiveness of amiloride toinhibit cyst growth appeared to increase with
longer application of the drug.
10 100 1000 10 100
Amiloride, ,sM
1384 Grantham et a!: Modification of cyst growth
Table 1. Relative inhibition of cyst enlargement by amiloride analogs
Relative transport inhibitory activity° MDCK cyst
inhibitory
activity IC50 ai'
Epithelial
stratificationc Reversibility"Drug
Na
channel
Na/H
exchange
Na/Ca
exchange
Amiloride 1 1 I 710 0 +
MK-875 0.6 <0.08 <0.08 >5000 0
DMA nil 12 2 28 + +
HMA nil 524 II 17 + +
DCB 4 nil 37 10 + +
MIBA nil 190 9 7 + +
EIPA nil 223 9 4 + +
CBDMB nil nil 150 2 + +
a Relative transport inhibitory activity—All values in the table supplied by E. J. Cragoe, Jr., are relative to amiloride. The amiloride K1 (sM) for
the: Na channel 0.34 [39]; Na/H antiporter 83.8 [40], 7 [41], 4 [42], and 3 [43]; and for the Na/Ca antiporter 1100 [44]. Amiloride analogs
can be found in [45].
b
1C50—Drug concentration that reduced cyst growth by 50% at the 3 to 7 day interval,
C Epithelial stratification—Determined by light microscopy. Cells arranged as monolayers (0) or highly stratified (+ + +).
d Reversibility—(+) indicates that cysts continued to grow after the drug, at levels IC50 concentration, was removed.
(U
-c
0
0)
0
00
0
C(U0
(U
a-
0.1 1.0 10 100 1000 10,000
Inhibitor, ,.iM
Fig. 7. Effect of amiloride and amiloride analogs on MDCK cyst
growth in medium-hydrated collagen gel. Drugs were added on day 0.
Results are shown for growth rates relative to control for the intervals
I to 3 and 3 to 7 days after adding the drugs. The amiloride data
represent the average of the 3 experiments shown in Figure 6. Repre-
sentative experiments are shown for the other drugs.
growth behavior of cyst cells vis a vis cells in monolayer
culture, we determined the effect on MDCK cysts of a progres-
sive increase in medium osmolality. Osmolality was increased
by adding NaCI to the medium in relatively small (20 mOsm!
day) or large increments (100 mOsm/5 days). In both protocols
the total increase in medium osmolality after 15 days was the
same (+300 mOsm). Hyperosmolality had no effect on the rate
of cyst enlargement (Fig. 3). The foregoing studies indicated
that MDCK cells grown in cyst configuration respond to me-
dium growth conditions similar to MDCK cells grown in mono-
layer cultures atop culture grade plastic.
Intracyst hydrostatic pressure was measured in isolated cysts
in FBS growth medium (37°C). The pressure within each of nine
cysts 350 to 700 tm in diameter was consistently higher than in
the bath; range 1.] to 12.4 mm H20, mean + 6.7 3.1 (SD).
There was no apparent relationship between cyst diameter and
cyst pressure.
The interior surfaces of the cyst walls could be brought into
focus so that individual cell outlines were easily recognized
(Fig. 4A). The linear regression equation (apical surface areal
cell, m2) = 0.0723 (cyst diameter, jim) + 134.5 describes the
relation between outer cyst diameter of 85 cysts in control
medium and the average apical plane surface area of cells within
those same cysts (data not shown). For example, the mean
apical surface area of cysts 100 jim in diameter is 142 jim2,
whereas for cysts with 800 jim diameters the mean apical
surface area of individual cells is 192 jim2. Thus, mean cell area
increased to a modest extent as cyst diameter increased, but not
nearly enough to account for cyst enlargement as due to simple
stretching of the cyst wall. Clearly, there was an increase in
total cell number as each cyst expanded, and this number could
be estimated from ii D2/mean cell area (Fig. 4B). The number of
cells in the 85 control cysts increased in direct linear proportion
to the increase in total surface area (Fig. 4B).
In established cysts (50 to 100 jim diameter on Day 0)
exposure to amiloride at concentrations greater than 250 jiM for
10 days consistently inhibited cyst enlargement (Figs. 5, 6, 7).
Amiloride inhibition of cyst enlargement was detected as early
as three days after adding the drug, but the potency of the
inhibition increased with longer exposure time (Fig. 6). The
amiloride effect on cyst enlargement was reversible since inhib-
ited cysts expanded when submaximal concentrations of the
drug were deleted from the medium (data not shown).
Several amiloride analogs were more potent inhibitors of cyst
growth than the parent compound (Fig. 7, Table 1). The potent
inhibition caused by CBDMB, EIPA, MIBA, and DCB was
typified by steep concentration dependent responses. HMA and
DMA had concentration dependent responses that were less
steep than the more potent amiloride analogs. MK-875 was
ineffective and, therefore, served as a control for the nonspe-
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Table 2. Relative inhibition of cyst enlargement by transport inhibitorsa
Targeted processesb
MDCK cystNa dependent
Na + K Carbonic KCl Na, K, C1 Cl/HCO3 inhibitory activity Epithelial
Drug ATPase anhydrase co-transport co-transport exchange 1C50M stratification Reversibility
Ouabain + 0.01 +++ +
NaVO3 + 27 +++ +
Bumetanide + + 440 ÷ +
Ethacrynic acid + + 36 +÷ +
L-645, 695 + + 37 ++ + +
L-644, 711 + >100 0
Acetazolamide + >100 0
See legend to Table
b Targeted processes—Transport processes that are the primary site of drug action, as opposed to alterations in transporter activity due to
secondary factors, such as changes in transmembrane ion gradients.
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Fig. 8. The effect of solute transport inhibitors on MDCK cysts in
medium-hydrated collagen gel. Drugs were added on day 0. Results are
shown for growth rates relative to control for the intervals I to 3 and 3
to 7 days after adding the drugs. Representative experiments are
shown.
cific effects of these compounds. The effect on cyst enlargement
of the highly and moderately potent inhibitors was observed
within one to three days (Fig. 7). At concentrations near the
IC50 levels cysts continued to expand when the inhibitors were
removed from the medium (data not shown).
We also examined the effect on cyst enlargement of inhibitors
with major actions on transport processes unaffected by amil-
oride (Fig. 8, Table 2). Low concentrations of ouabain, an Na +
K, ATPase inhibitor, slowed the rate of cyst growth, and the
drug had a rapid onset of action. The ouabain effect was
reversible except for concentrations higher than 0.5 M. Van-
adate retarded cyst growth and had a rapid onset of action,
although higher concentrations of this Na + K, ATPase inhib-
itor than ouabain were required to inhibit cyst enlargement.
Ethacrynic acid inhibited cyst enlargement and was more
potent than bumetanide, another Na, K, 2C1 cotransport inhib-
itor. L-645,695 inhibits Na-dependent Cf /HC03 exchange
and KCl transport in erythrocytes [30]. This drug inhibited
cyst growth, whereas L-644,711, an analog that blocks Na-
dependent C1/HC03 exchange, but has no effect on KCl
transport in erythrocytes [30], had no effect on cyst growth.
(Data not shown.) Acetazolamide, a potent inhibitor of carbonic
anhydrase, had no effect on cyst growth at concentrations up to
100 M (Table 2).
Effects of drugs on cyst morphology
Three of the drugs that reduced the rate of cyst enlargement
also caused distinct changes in the morphologic appearance of
the cell layer. Ouabain, vanadate, and L-645,695 caused im-
pressive wall thickening in 80 to 100% of the treated cysts,
whereas in control cysts wall thickening was seen in less than
5% of cysts (Fig. 9. Table 2). Light and electron micrographs of
the treated cysts revealed a striking increase in the number of
cells in the cyst walls, with stratification into layers more than
2 cells in thickness. In some cysts cell amplification was so
pronounced that the lumen was obliterated. The morphologic
effect was monitored in all living cysts by light microscopy. The
cysts were graded 0 to + + + according to the extent to which
the cyst walls were thickened. Zero indicated no thickening
greater than control, and + + + indicated extreme wall thicken-
ing of the type displayed for ouabain in Figure 9. Grades + and
+ + reflected lesser degrees of wall thickening. Ouabain, van-
adate and L-645,695 graded + + + by this method, but bumeta-
nide, ethacrynic acid, EIPA, MIBA, CBDMB, DCB, DMA,
and HMA caused much less obvious changes in cell wall
morphology. Amiloride, MK-875, and acetazolamide had no
discernible effect on wall thickness.
In cysts that had stopped expanding but continued to add
cells to the epithelial wall, it is reasonable to suppose that
ouabain, vanadate, and L-645,695 had reduced the accumula-
tion of fluid in the cyst cavity to a greater extent than they had
retarded the rate of epithelial proliferation. By contrast, the
other drugs that slowed cyst enlargement but did not cause
amplification of cell numbers in the cyst walls evidently reduced
cell proliferation and net transepithelial fluid secretion to about
the same extent (Fig. 10). These conclusions are supported by
the observations that when concentrations that slowed the rate
of overall cyst enlargement by 50% were administered ouabain
I I -
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Fig. 9. Effect of ouabain on cyst epithelial morphology. a,c,e. Control cyst cross-section examined by light microscopy in vitro (a, 115 x: marker
87 gm), by light microscopy of a stained cross section (C, 114 x), and by electron microscopy (e, 2500 x; marker 10 pm). b,d,f. Cysts treated with
ouabain (10-v M) and examined by light microscopy in vitro (b), by light microscopy of a stained cross section (d), and by electron microscopy
(0. Magnifications of a,b,c,d; and e,f were identical. Note the single layer of cells in the control cysts, and the thickened walls and stratified cell
layer in the ouabain-treated cysts. L, lumen.
caused an increase in the number of cells in the treated cyst have retarded fluid accumulation and cell proliferation to the
relative to the untreated control cysts of the same size (Fig. 9). same degree, since the number of cells per unit surface area was
By contrast, in amiloride-treated cysts the number of cells in not different between control and treated cysts.
treated and control cysts remained the same (Fig. 10). The most
economical explanation is to suppose that ouabain diminished Discussion
net fluid secretion to a greater extent than it decreased cell We have used an in vitro model to demonstrate that the rate
proliferation, thereby leading to a piling up of cells in the cyst of renal epithelial cyst enlargement can be regulated by agents
wall. On the other hand, amiloride and amiloride analogs must that influence solute transport or cell proliferation. Since
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Amiloride
B 500p.M
Amiloride
C 1000 p.M
MDCK cells obtained from American Type and Culture Collec-
tion may be heterogenous, we confined our studies to cells
subcultured from a single cyst that most likely developed from
a single MDCK cell [7, 8, 31]. The enlargement of cysts derived
from this subculture was stimulated by PGEJ, and growth was
sustained in hyperosmotic medium. Preliminary studies also
confirm that the cysts are highly impermeable to water (R.
Mangoo-Karim and J. Grantham, unpublished observations).
In the control state a single layer of epithelial cells was
maintained as the cysts expanded to diameters exceeding 1000
rm. The number of cells in the walls of each cyst increased in
direct proportion to the increase in plane surface area of the
cysts (Fig. 4B). It is clear, therefore, that the rate of increase of
total plane surface area of these spherical cysts reflected the
rate of increase in the number of MDCK cells lining the cyst's
walls, a finding that is in concert with the general view that cell
proliferation is a central element in the sustained enlargement of
renal cysts [6].
Dissection of individual cysts from the collagen matrix
proved that the cavities contained liquid since inadvertent tears
in the wall in the course of dissection caused the cysts to
collapse. Moreover, transmural micropuncture of intact dis-
sected cysts revealed a standing hydrostatic pressure on the
average 6.7 mm H20 greater than in the medium. The positive
pressure gradient observed in all the punctured cysts indicates
that fluid entry is dependent on active solute transport, rather
than the consequence of a negative cavitary pressure created by
proliferating epithelial cells that could literally suck fluid into
the cavity.
It is reasonable to assume that the movement of solutes
across these cells is probably opposite to the usual absorptive
direction of net flow in monolayer cultures that form hemicysts
or domes [32]. Preliminary studies of cyst fluid concentration of
Na, K and C1 measured by electron probe, reveal that these
ions are transported into the cavity (R. Mangoo-Karim, C.
Lechene and J. Grantham, unpublished studies). In response to
stimulated production of intracellular cyclic AMP, confluent
monolayers of MDCK cells cultured on permeable supports
secrete chloride into the solution bathing the apical cell surfaces
[33, 34]. The extent to which net chloride secretion is coupled to
fluid movement has not been examined in MDCK cells, al-
though in other tissues fluid secretion coupled to chloride
transport has been confirmed [35]. In MDCK cells chloride
secretion in the basolateral to apical direction involves Na +K, ATPase, Na, K, 2C1 cotransport, and C1 and K
channels as in other specialized secretory epithelia [34, 35].
Conceivably, the arrangement of MDCK cells into cysts per-
mits a secretory chloride transport process to be expressed in
the coupled movement of chloride and fluid into the closed
intracystic compartment.
Drugs that alter solute transport may slow the rate of MDCK
cyst enlargement by interfering with the secretion of fluid into
the cyst cavity or possibly, by decreasing the rate of cell
proliferation. Ouabain, vanadate, and L-645,695 slowed the rate
of cyst enlargement and caused stratification of the cells in the
cyst walls. Since there were more cells per unit surface area or
perimeter in treated than in control cyst walls (Fig. 9), it seems
clear that these drugs decreased the rate of fluid accumulation,
but did not cause a proportionate reduction in the rate of cell
proliferation. This observation indicates that in the MDCK
model of renal cysts, fluid accumulation and cellular prolifera-
tion are not obligatorily linked.
In the current study the IC50 for the inhibition of cyst
enlargement by ouabain (1.1 x 10_8 M) was lower than the
concentration that inhibits proliferation of subconfluent cul-
tures of MDCK cells on plastic (IC50, S x l0 M) [12]. This
finding supports the suggestion that relatively low concentra-
tions of ouabain may inhibit secretory (basolateral to apex)
solute and fluid transport without abolishing cell proliferation.
It is unlikely that ouabain treatment selected out cells that have
no fluid secretory capacity, since the cysts filled with fluid again
when ouabain was removed from the medium. The uncoupling
of net fluid secretion and cellular proliferation apparently leads
to cysts that continue to expand slowly, but become progres-
sively filled with cells rather than fluid. These observations lead
to the supposition that epithelial cysts could be changed into
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Fig. 10. Effect of amiloride on the number of
cells in MDCK cysts of comparable size. Cyst5000 surface area was determined from
measurements of cyst diameter. The number
10000 ofcells per cyst was determined by dividingtotal surface area by the plane surface area of
individual cells determined by morphometric
5000 analysis (See Fig. 4A and 4B). Amiloride at
concentrations sufficient to reduce the rate of
cyst enlargement by more than 50% had no
effect on the number of cells per unit surface
area since the slopes of the regression lines
were not different.Cyst surface area, 104cm2
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solid tissue masses, and vice versa, depending on the extent to
which net solute and fluid secretion are stimulated.
Vanadate caused morphologic effects identical to that pro-
duced by ouabain presumably by inhibiting Na + K, ATPase
[36]. Inhibition of the sodium pump is evidently not required to
produce hypercellular cysts, however, since L-645,695, a com-
pound that blocks Nat-dependent Cl/HCO3 exchange [37] and
KCI efflux [30] produced an identical morphological picture to
that caused by ouabain. It appears, therefore, that selective
inhibition of several solute transport processes can reduce cyst
enlargement by diminishing fluid accumulation primarily.
Amiloride and amiloride analogs diminished the rate of cyst
expansion with varying degrees of intensity. At concentrations
of the agents that reduced cyst expansion by 50%, there was no
apparent effect on the number of cells per unit surface area (Fig.
10, Table 1). It would appear, therefore, that unlike ouabain,
vanadate and L-645,695, the amiloride class of drugs inhibited
cell proliferation and fluid transport to about the same degree.
The potency of inhibition correlated best with the extent to
which the drugs inhibited Na-dependent Ca transport in a
variety of cells (Table I). There was no correlation between the
effect of these agents and their propensity to inhibit conductive
Na4 channels or Nat-dependent H transport.
The current study establishes the feasibility that one day
drugs may be found that can slow or halt in situ the enlargement
of cysts derived from renal epithelium. The results indicate
clearly that inhibition of cellular proliferation or fluid secretion
can slow or halt the enlargement of established cysts that have
no source of cavitary fluid other than that derived from trans-
epithelial secretion.
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Appendix 1. Abbreviations
Amiloride, AMIL
5-(N-ethyl-N-isopropyl)amiloride, EIPA
5-(N-methyl-N-isobutyl)amiloride, MIBA
5-(N,N-hexamethylene)amiloride, HMA
5-(N,N-dimethyl)amiloride, DMA
3' ,4'-dichlorobenzamil, DCB
5-[N-(4-chlorobenzyl)]-2' ,4'-dimethylbenzamil, CBDMB
Madin-Darby canine kidney, MDCK
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